Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
批准号:
10601295
负责人:
VALERI VASIOUKHIN
金额:
$6.24万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-07 至 2024-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Normal tissue homeostasis is maintained by adult stem and progenitor cells that use cell intrinsic
mechanisms and information from their microenvironment to execute a very complex specialized type
of mitosis known as asymmetric cell division. Two resulting from this division daughter cells acquire
different cell fates. While one cell continues proliferation, another daughter cell withdraws from the stem
cell niche, remodels its intercellular interactions and starts a program which ultimately leads to the cell
cycle withdrawal and differentiation. This process ensures that only the necessary number of cells is
produced at any given time and the cell death and depletion in each tissue is balanced by the birth of
new cells. Defective asymmetric cell division can result in the failure of normal tissue homeostasis and
birth of cancer stem cells, which cannot produce daughters that can properly withdraw from the cell
cycle and differentiate. While asymmetric cell division plays a pivotal role in tissue homeostasis, little
is known about its mechanisms in mammalian organisms. Studies in model organisms revealed critical
role of intercellular interactions and apical-basal cell polarity in regulation of asymmetric cell division.
In Drosophila, basal cell polarity gene lethal giant larvae (lgl) was identified as an important regulator
of asymmetric cell division, and mutations in lgl result in overproduction of dividing stem cells and
development of cancer. Mammalian genomes contain two lgl orthologs Llgl1 and Llgl2. While previous
studies of LLGL1 and LLGL2 in cancer cell lines indicated their potential role as tumor suppressors,
genetic analysis of these genes in mice was complicated by the genetic redundancy and lethality of Llgl
mutants. We have now generated conditional, tissue specific Llgl1/2 double knockout mice. Our
preliminary experiments revealed tumor-suppressive function of Llgl1/2 in skin squamous cell
carcinoma. In this grant, we propose to use our mutant animals, primary cell cultures and in utero
lentiviral transduction of skin epidermis to reveal the role and molecular mechanisms of Llgl gene family
in stem and progenitor cells during normal tissue homeostasis and cancer. These studies will help to
understand the mechanisms of mammalian stem and progenitor cells self-renewal and differentiation
and the role of these mechanisms in cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
-
批准号:10406262
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2019
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
-
批准号:10667590
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2019
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
-
批准号:9814413
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2019
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
-
批准号:10158454
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2019
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
-
批准号:8643463
-
项目类别:
-
资助金额:$43.55万
-
财政年份:2014
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
-
批准号:9057992
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2014
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Regulation of Hippo Signaling by Src-Family Kinases
-
批准号:8764489
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2014
-
负责人:VALERI VASIOUKHIN
-
依托单位:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
-
批准号:9228337
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:VALERI VASIOUKHIN
-
依托单位:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
-
批准号:8517420
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2013
-
负责人:VALERI VASIOUKHIN
-
依托单位:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
-
批准号:9005838
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:VALERI VASIOUKHIN
-
依托单位:
The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer
-
批准号:8641334
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2013
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Cell Polarity in Self-renewal and Differentiation of Stem/Progenitor Cells
-
批准号:8193122
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2009
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Cell Polarity in Self-renewal and Differentiation of Stem/Progenitor Cells
-
批准号:8278663
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2009
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Cell Polarity in Self-renewal and Differentiation of Stem/Progenitor Cells
-
批准号:7589619
-
项目类别:
-
资助金额:$35.51万
-
财政年份:2009
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Cell Polarity in Self-renewal and Differentiation of Stem/Progenitor Cells
-
批准号:7860514
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2009
-
负责人:VALERI VASIOUKHIN
-
依托单位:
ROLE OF ALPHAE-CATENIN IN REGULATION OF BRAIN SIZE AND BRAIN CANCER
-
批准号:7602126
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2007
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Invasion and Metastasis in Prostate Cancer
-
批准号:7662203
-
项目类别:
-
资助金额:$31.71万
-
财政年份:2004
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Invasion and metastasis in prostate cancer
-
批准号:6778884
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2004
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Invasion and metastasis in prostate cancer
-
批准号:6891470
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2004
-
负责人:VALERI VASIOUKHIN
-
依托单位:
Invasion and metastasis in prostate cancer
-
批准号:7061236
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2004
-
负责人:VALERI VASIOUKHIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: